<iframe src="//www.googletagmanager.com/ns.html?id=GTM-5TSRKG" height="0" width="0" style="display: none; visibility: hidden">
Research Article
No access
Published Online: 23 August 2012

Design and Fabrication of a Biodegradable, Covalently Crosslinked Shape-Memory Alginate Scaffold for Cell and Growth Factor Delivery

Publication: Tissue Engineering Part A
Volume 18, Issue Number 19-20

Abstract

The successful use of transplanted cells and/or growth factors for tissue repair is limited by a significant cell loss and/or rapid growth factor diffusion soon after implantation. Highly porous alginate scaffolds formed with covalent crosslinking have been used to improve cell survival and growth factor release kinetics, but require open-wound surgical procedures for insertion and have not previously been designed to readily degrade in vivo. In this study, a biodegradable, partially crosslinked alginate scaffold with shape-memory properties was fabricated for minimally invasive surgical applications. A mixture of high and low molecular weight partially oxidized alginate modified with RGD peptides was covalently crosslinked using carbodiimide chemistry. The scaffold was compressible 11-fold and returned to its original shape when rehydrated. Scaffold degradation properties in vitro indicated ∼85% mass loss by 28 days. The greater than 90% porous scaffolds released the recombinant growth factor insulin-like growth factor-1 over several days in vitro and allowed skeletal muscle cell survival, proliferation, and migration from the scaffold over a 28-day period. The compressible scaffold thus has the potential to be delivered by a minimally invasive technique, and when rehydrated in vivo with cells and/or growth factors, could serve as a temporary delivery vehicle for tissue repair.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Hill E.Boontheekul T.Mooney D.J. Regulating activation of transplanted cells controls tissue regenerationProc Natl Acad Sci U S A10324942006.1. Hill, E., Boontheekul, T., and Mooney, D.J. Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci U S A 103, 2494, 2006.
2.
Tedesco F.S.Dellavalle A.Diaz-Manera J.Messina G.Cossu G. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cellsJ Clin Invest120112010. 2. Tedesco, F.S., Dellavalle, A., Diaz-Manera, J., Messina, G., and Cossu, G. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120, 11, 2010.
3.
Qu Z.Balkir L.van Deutekom J.C.Robbins P.D.Pruchnic R.Huard J. Development of approaches to improve cell survival in myoblast transfer therapyJ Cell Biol14212571998. 3. Qu, Z., Balkir, L., van Deutekom, J.C., Robbins, P.D., Pruchnic, R., and Huard, J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142, 1257, 1998.
4.
Beauchamp J.R.Morgan J.E.Pagel C.N.Partridge T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic sourceJ Cell Biol14411131999. 4. Beauchamp, J.R., Morgan, J.E., Pagel, C.N., and Partridge, T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144, 1113, 1999.
5.
Drury J.L.Mooney D.J. Hydrogels for tissue engineering: scaffold design variables and applicationsBiomaterials2443372003. 5. Drury, J.L., and Mooney, D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24, 4337, 2003.
6.
Bouhadir K.H.Hausman D.S.Mooney D.J. Synthesis of cross-linked poly(aldehyde guluronate) hydrogelsPolymer4035751999. 6. Bouhadir, K.H., Hausman, D.S., and Mooney, D.J. Synthesis of cross-linked poly(aldehyde guluronate) hydrogels. Polymer 40, 3575, 1999.
7.
Lendlein A.Kelch S. Shape-memory polymers as stimuli-sensitive implant materialsClin Hemorheol Micro321052005. 7. Lendlein, A., and Kelch, S. Shape-memory polymers as stimuli-sensitive implant materials. Clin Hemorheol Micro 32, 105, 2005.
8.
Lendlein A.Langer R. Biodegradable, elastic shape-memory polymers for potential biomedical applicationsScience29616732002. 8. Lendlein, A., and Langer, R. Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 296, 1673, 2002.
9.
Thornton A.J.Alsberg E.Albertelli M.Mooney D.J. Shape-defining scaffolds for minimally invasive tissue engineeringTransplantation7717982004. 9. Thornton, A.J., Alsberg, E., Albertelli, M., and Mooney, D.J. Shape-defining scaffolds for minimally invasive tissue engineering. Transplantation 77, 1798, 2004.
10.
Thornton A.J.Alsberg E.Hill E.E.Mooney D.J. Shape retaining injectable hydrogels for minimally invasive bulkingJ Urol1727632004. 10. Thornton, A.J., Alsberg, E., Hill, E.E., and Mooney, D.J. Shape retaining injectable hydrogels for minimally invasive bulking. J Urol 172, 763, 2004.
11.
Gates C.Huard J. Management of skeletal muscle injuries in military personnelOper Tech Sports Med132472005. 11. Gates, C., and Huard, J. Management of skeletal muscle injuries in military personnel. Oper Tech Sports Med 13, 247, 2005.
12.
Kong H.J.Lee K.Y.Mooney D.J. Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentrationPolymer4362392002. 12. Kong, H.J., Lee, K.Y., and Mooney, D.J. Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentration. Polymer 43, 6239, 2002.
13.
Boontheekul T.Kong H.J.Mooney D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distributionBiomaterials2624552005. 13. Boontheekul, T., Kong, H.J., and Mooney, D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26, 2455, 2005.
14.
Rowley J.A.Madlambayan G.Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materialsBiomaterials20451999. 14. Rowley, J.A., Madlambayan, G., and Mooney, D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45, 1999.
15.
Lee K.Y.Rowley J.A.Eiselt P.Moy E.M.Bouhadir K.H.Mooney D.J. Controlling mechanical and swelling properties of alginate hydrogels independently by cross-linker type and cross-linking densityMacromolecules3342912000. 15. Lee, K.Y., Rowley, J.A., Eiselt, P., Moy, E.M., Bouhadir, K.H., and Mooney, D.J. Controlling mechanical and swelling properties of alginate hydrogels independently by cross-linker type and cross-linking density. Macromolecules 33, 4291, 2000.
16.
Shapiro L.Cohen S. Novel alginate sponges for cell culture and transplantationBiomaterials185831997. 16. Shapiro, L., and Cohen, S. Novel alginate sponges for cell culture and transplantation. Biomaterials 18, 583, 1997.
17.
Eiselt P.Yeh J.Latvala R.K.Shea L.D.Mooney D.J. Porous carriers for biomedical applications based on alginate hydrogelsBiomaterials2119212000. 17. Eiselt, P., Yeh, J., Latvala, R.K., Shea, L.D., and Mooney, D.J. Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials 21, 1921, 2000.
18.
Thorrez L.Shansky J.Wang L.Fast L.VandenDriessche T.Chuah M.Mooney D.Vandenburgh H. Growth, differentiation, transplantation and survival of human skeletal myofibers on biodegradable scaffoldsBiomaterials29752008. 18. Thorrez, L., Shansky, J., Wang, L., Fast, L., VandenDriessche, T., Chuah, M., Mooney, D., and Vandenburgh, H. Growth, differentiation, transplantation and survival of human skeletal myofibers on biodegradable scaffolds. Biomaterials 29, 75, 2008.
19.
Richards H.A.Halfhill M.D.Millwood R.J.Stewart C.N. Quantitative GFP fluorescence as an indicator of recombinant protein synthesis in transgenic plantsPlant Cell Rep221172003. 19. Richards, H.A., Halfhill, M.D., Millwood, R.J., and Stewart, C.N. Quantitative GFP fluorescence as an indicator of recombinant protein synthesis in transgenic plants. Plant Cell Rep 22, 117, 2003.
20.
Soboleski M.R.Oaks J.Halford W.P. Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cellsFASEB J194402005. 20. Soboleski, M.R., Oaks, J., and Halford, W.P. Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB J 19, 440, 2005.
21.
Alshamkhani A.Duncan R. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in-vivoJ Bioactive Compat Polym1041995. 21. Alshamkhani, A., and Duncan, R. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in-vivo. J Bioactive Compat Polym 10, 4, 1995.
22.
Semenov V.V. Archeological and forensic science biological object search—by using ultraviolet radiation of prescribed energy density and recording phosphorescence signal on colour reversible filmDerwent Innovations Index, Soviet Union19895. 22. Semenov, V.V. Archeological and forensic science biological object search—by using ultraviolet radiation of prescribed energy density and recording phosphorescence signal on colour reversible film. Derwent Innovations Index, Soviet Union, 1989, p. 5.
23.
Ikada Y. Challenges in tissue engineeringJ R Soc Interface35892006. 23. Ikada, Y. Challenges in tissue engineering. J R Soc Interface 3, 589, 2006.
24.
Engert J.C.Berglund E.B.Rosenthal N. Proliferation precedes differentiation in IGF-I-stimulated myogenesisJ Cell Biol1354311996. 24. Engert, J.C., Berglund, E.B., and Rosenthal, N. Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J Cell Biol 135, 431, 1996.
25.
Rosenthal S.M.Cheng Z.Q. Opposing early and late effects of insulin-like growth-factor-i on differentiation and the cell-cycle regulatory retinoblastoma protein in skeletal myoblastsProc Natl Acad Sci U S A92103071995. 25. Rosenthal, S.M., and Cheng, Z.Q. Opposing early and late effects of insulin-like growth-factor-i on differentiation and the cell-cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci U S A 92, 10307, 1995.
26.
Boontheekul T.Hill E.E.Kong H.J.Mooney D.J. Regulating myoblast phenotype through controlled gel stiffness and degradationTissue Eng1314312007. 26. Boontheekul, T., Hill, E.E., Kong, H.J., and Mooney, D.J. Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng 13, 1431, 2007.
27.
Borselli C.Storrie H.Benesch-Lee F.Shvartsman D.Cezar C.Lichtman J.W.Vandenburgh H.H.Mooney D.J. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factorsProc Natl Acad Sci U S A1073287. 27. Borselli, C., Storrie, H., Benesch-Lee, F., Shvartsman, D., Cezar, C., Lichtman, J.W., Vandenburgh, H.H., and Mooney, D.J. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A 107, 3287.
28.
Borselli C.Cezar C.A.Shvartsman D.Vandenburgh H.H.Mooney D.J. The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regenerationBiomaterials3289052011. 28. Borselli, C., Cezar, C.A., Shvartsman, D., Vandenburgh, H.H., and Mooney, D.J. The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials 32, 8905, 2011.
29.
Guler H.P.Zapf J.Schmid C.Froesch E.R. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production ratesActa Endocrinol (Copenh)1217531989. 29. Guler, H.P., Zapf, J., Schmid, C., and Froesch, E.R. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121, 753, 1989.
30.
Lewitt M.S.Saunders H.Cooney G.J.Baxter R.C. Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in ratsJ Endocrinol1362531993. 30. Lewitt, M.S., Saunders, H., Cooney, G.J., and Baxter, R.C. Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats. J Endocrinol 136, 253, 1993.
31.
Pan W.Kastin A.J. Interactions of IGF-1 with the blood-brain barrier in vivo and in situNeuroendocrinology721712000. 31. Pan, W., and Kastin, A.J. Interactions of IGF-1 with the blood-brain barrier in vivo and in situ. Neuroendocrinology 72, 171, 2000.
32.
Charge S.B.P.Rudnicki M.A. Cellular and molecular regulation of muscle regenerationPhysiol Rev842092004. 32. Charge, S.B.P., and Rudnicki, M.A. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84, 209, 2004.
33.
Philippou A.Halapas A.Maridaki M.Koutsilieris M. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophyJ Musculoskelet Neuronal Interact72082007. 33. Philippou, A., Halapas, A., Maridaki, M., and Koutsilieris, M. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J Musculoskelet Neuronal Interact 7, 208, 2007.
34.
Adams G.R. Invited review: autocrine/paracrine IGF-I and skeletal muscle adaptationJ Appl Physiol9311592002. 34. Adams, G.R. Invited review: autocrine/paracrine IGF-I and skeletal muscle adaptation. J Appl Physiol 93, 1159, 2002.
35.
Yang S.Y.Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiationFEBS Lett5221562002. 35. Yang, S.Y., and Goldspink, G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 522, 156, 2002.

Information & Authors

Information

Published In

cover image Tissue Engineering Part A
Tissue Engineering Part A
Volume 18Issue Number 19-20October 2012
Pages: 2000 - 2007
PubMed: 22646518

History

Published in print: October 2012
Published online: 23 August 2012
Published ahead of production: 30 May 2012
Accepted: 2 May 2012
Received: 23 November 2011

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Lin Wang
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, Rhode Island.
School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts.
Janet Shansky
Myomics, Inc., Providence, Rhode Island.
Cristina Borselli
School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts.
David Mooney
School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts.
Herman Vandenburgh
School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts.
Myomics, Inc., Providence, Rhode Island.
Department of Pathology, Brown Medical School, Providence, Rhode Island.

Notes

Address correspondence to:Herman Vandenburgh, Ph.D.Myomics, Inc.148 West River St., Suite 1FProvidence, RI 02904E-mail: [email protected]

Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top